Ronald Silver's most recent trade in Ironwood Pharmaceuticals Inc - Ordinary Shares - Class A was a trade of 12,048 Class A Common Stock done at an average price of $1.8 . Disclosure was reported to the exchange on Feb. 10, 2025.
Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|---|
Ironwood Pharmaceuticals I... | Ronald Silver | Principal Accounting Officer | Sale of securities on an exchange or to another person at price $ 1.76 per share. | 10 Feb 2025 | 12,048 | 279,655 (0%) | 0% | 1.8 | 21,204 | Class A Common Stock |
Ironwood Pharmaceuticals I... | Ronald Silver | Principal Accounting Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Jan 2025 | 133,333 | 291,703 (0%) | 0% | 0 | Class A Common Stock | |
Ironwood Pharmaceuticals I... | Ronald Silver | Principal Accounting Officer | Sale of securities on an exchange or to another person at price $ 4.27 per share. | 12 Aug 2024 | 3,107 | 158,370 (0%) | 0% | 4.3 | 13,267 | Class A Common Stock |
Ironwood Pharmaceuticals I... | Silver Ronald | Principal Accounting Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Feb 2024 | 27,213 | 161,477 (0%) | 0% | 0 | Class A Common Stock | |
Ironwood Pharmaceuticals I... | Ronald Silver | Principal Accounting Officer | Sale of securities on an exchange or to another person at price $ 15.24 per share. | 12 Feb 2024 | 7,908 | 134,264 (0%) | 0% | 15.2 | 120,518 | Class A Common Stock |
Ironwood Pharmaceuticals I... | Ronald Silver | Principal Accounting Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Aug 2023 | 8,000 | 142,172 (0%) | 0% | 0 | Class A Common Stock | |
Ironwood Pharmaceuticals I... | Ronald Silver | Principal Accounting Officer | Sale of securities on an exchange or to another person at price $ 10.04 per share. | 14 Aug 2023 | 1,976 | 134,172 (0%) | 0% | 10.0 | 19,839 | Class A Common Stock |
Ironwood Pharmaceuticals I... | Ronald Silver | Principal Accounting Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Mar 2023 | 35,620 | 134,111 (0%) | 0% | 0 | Class A Common Stock | |
Ironwood Pharmaceuticals I... | Ronald Silver | Principal Accounting Officer | Sale of securities on an exchange or to another person at price $ 11.31 per share. | 27 Feb 2023 | 3,049 | 98,491 (0%) | 0% | 11.3 | 34,484 | Class A Common Stock |
Ironwood Pharmaceuticals I... | Ronald Silver | Principal Accounting Officer | Sale of securities on an exchange or to another person at price $ 11.41 per share. | 27 Feb 2023 | 2,929 | 101,540 (0%) | 0% | 11.4 | 33,420 | Class A Common Stock |
Ironwood Pharmaceuticals I... | Ronald Silver | Principal Accounting Officer | Sale of securities on an exchange or to another person at price $ 11.56 per share. | 21 Nov 2022 | 682 | 104,469 (0%) | 0% | 11.6 | 7,884 | Class A Common Stock |
Ironwood Pharmaceuticals I... | Ronald Silver | Principal Accounting Officer | Sale of securities on an exchange or to another person at price $ 11.77 per share. | 15 Aug 2022 | 2,014 | 105,151 (0%) | 0% | 11.8 | 23,705 | Class A Common Stock |
Ironwood Pharmaceuticals I... | Ronald Silver | Principal Accounting Officer | Sale of securities on an exchange or to another person at price $ 11.50 per share. | 23 May 2022 | 120 | 105,073 (0%) | 0% | 11.5 | 1,380 | Class A Common Stock |
Ironwood Pharmaceuticals I... | Ronald Silver | Principal Accounting Officer | Sale of securities on an exchange or to another person at price $ 12.75 per share. | 24 Mar 2022 | 3,031 | 105,193 (0%) | 0% | 12.7 | 38,645 | Class A Common Stock |
Ironwood Pharmaceuticals I... | Ronald Silver | Principal Accounting Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Mar 2022 | 30,000 | 108,224 (0%) | 0% | 0 | Class A Common Stock | |
Ironwood Pharmaceuticals I... | Ronald Silver | Principal Accounting Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Mar 2022 | 17,013 | 78,224 (0%) | 0% | 0 | Class A Common Stock | |
Ironwood Pharmaceuticals I... | Ronald Silver | Principal Accounting Officer | Sale of securities on an exchange or to another person at price $ 10.77 per share. | 28 Feb 2022 | 1,150 | 61,211 (0%) | 0% | 10.8 | 12,386 | Class A Common Stock |
Ironwood Pharmaceuticals I... | Ronald Silver | Principal Accounting Officer | Sale of securities on an exchange or to another person at price $ 10.77 per share. | 28 Feb 2022 | 640 | 62,361 (0%) | 0% | 10.8 | 6,893 | Class A Common Stock |
Ironwood Pharmaceuticals I... | Ronald Silver | Principal Accounting Officer | Sale of securities on an exchange or to another person at price $ 10.77 per share. | 28 Feb 2022 | 448 | 63,001 (0%) | 0% | 10.8 | 4,825 | Class A Common Stock |
Ironwood Pharmaceuticals I... | Ronald Silver | Principal Accounting Officer | Sale of securities on an exchange or to another person at price $ 11.58 per share. | 23 Nov 2021 | 749 | 61,926 (0%) | 0% | 11.6 | 8,673 | Class A Common Stock |
Ironwood Pharmaceuticals I... | Ronald Silver | Principal Accounting Officer | Sale of securities on an exchange or to another person at price $ 11.58 per share. | 23 Nov 2021 | 713 | 61,213 (0%) | 0% | 11.6 | 8,257 | Class A Common Stock |
Ironwood Pharmaceuticals I... | Ronald Silver | Principal Accounting Officer | Sale of securities on an exchange or to another person at price $ 13.48 per share. | 16 Aug 2021 | 567 | 62,675 (0%) | 0% | 13.5 | 7,643 | Class A Common Stock |
Ironwood Pharmaceuticals I... | Ronald Silver | Principal Accounting Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jul 2021 | 20,000 | 63,242 (0%) | 0% | 0 | Class A Common Stock |